Skip to main content
. 2022 Sep 13;13:965971. doi: 10.3389/fimmu.2022.965971

Figure 4.

Figure 4

Subgroup analysis of the neutralizing antibody seroconversion rates across variables. N, the total number of vaccinated participants assessing neutralizing antibodies for SARS-CoV-2; n, the number of participants with seroconversion.